MedDataX Logo

App-based Symptom Tracking After Corona Vaccination (CoCoV)

NCT ID: NCT04686409

Last Updated: 2020-12-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-11

Study Completion Date

2022-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study investigates the side effects of different COVID-19 vaccines.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this observational study side effects of COVID-19 vaccines will be documented using an open-source mobile application. Participants are invited to answer a questionnaire on a daily basis. Common and unknown events are queried and collected. The primary result of this study will be a descriptive analysis of the collected data.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adverse Events in COVID-19 Vaccination

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

COVID-19 vaccines

Participants will be vaccinated with one of the approved COVID-19 vaccines

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* received COVID-19 vaccination
* age ≥ 18 years
* mobile device (iOS or Android)

Exclusion Criteria

* No knowledge of German or English language
* No written informed consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Ulm

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Thomas Seufferlein

Professor, Head of Department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Seufferlein, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

University Hospital Ulm

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Universitätsklinikum Ulm

Ulm, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Thomas Seufferlein, Prof. Dr.

Role: CONTACT

Phone: +4973150044501

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CoCoV

Identifier Type: -

Identifier Source: org_study_id